Pharmacist-documented components of screening model completed (n=112)
| Component of screening model | N | (%) |
| Timing of screening | ||
| Immediately following recruitment | 100 | (91.7) |
| By appointment on same day | 3 | (2.8) |
| By appointment on another day | 6 | (5.5) |
| No. of visits needed to complete screening | ||
| One visit | 103 | (92.3) |
| Two visits | 4 | (3.7) |
| Assessments and measurements completed | ||
| Anthropometric measurements | 110 | (100.0) |
| Diabetes risk assessment | 111 | (100.0) |
| ASCVD risk score calculation | 110 | (100.0) |
| Dietary habits assessment | 111 | (100.0) |
| Physical activity habits assessment | 111 | (100.0) |
| Tests and measurements not completed | ||
| Lipid profile | 4 | (33.3) |
| HbA1c | 4 | (33.3) |
| Waist circumference | 3 | (25.0) |
| Blood pressure | 1 | (8.33) |
| Reason for not completing test/measurement | ||
| Technical error in device | 9 | (90.0) |
| Participant objection* | 1 | (10.0) |
| Assessment, testing and measurement duration | ||
| Mean duration±SD (min) | 27.0±9.4 | |
| 10–20 | 34 | (30.9) |
| 21–30 | 53 | (48.2) |
| 31–40 | 19 | (17.3) |
| Over 40 | 4 | (3.6) |
| Post-assessment counselling | ||
| ASCVD risk score interpretation | 110 | (100.0) |
| ADA questionnaire score interpretation | 107 | (100.0) |
| HbA1c result interpretation† | 79 | (96.3) |
| Guideline targets for suboptimal blood test results | 107 | (100.0) |
| Lifestyle behaviours (top two covered aspects) | ||
| Dietary behaviours | 91 | (85.8) |
| Physical activity | 86 | (81.1) |
| Need for further/confirmatory testing at physician’s office | 87 | (87.9) |
| Post-assessment counselling duration | ||
| Mean duration ±SD (min) | 11.6±6.5 | |
| 1–10 | 39 | (33.9) |
| 11–20 | 36 | (31.3) |
| 21–30 | 3 | (2.6) |
| Not reported | 37 | (32.2) |
*One participant objected to waist circumference measurement.
†Documentation was missing for 30 participants.
ADA, American Diabetes Association; ASCVD, atherosclerotic cardiovascular disease; HbA1c, glycated haemoglobin.